NASDAQ:LPTX

Leap Therapeutics Stock Insider Trading

etoro logo Buy LPTX
*Your capital is at risk
$0.690
+0 (+0%)
At Close: Jun 22, 2026

LEAP THERAPEUTICS Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 93.31. In total, the insiders bought 2.89M and sold 68.6K LPTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
93.31
Buy 2.89M shares
Sell 68.6K shares
84% Buy Activity
Moderate Negative Correlation
Sell Signal Low Confidence
Jun 22, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 93.31.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 30, 2025
Buy
Common Stock
J-Other
Baum Jason
Officer
Officer 0
Value: $0
Jun 30, 2025
Buy
Common Stock
J-Other
Lawlor Augustine
Officer
Officer 0
Value: $0
Jun 30, 2025
Buy
Common Stock
J-Other
O'mahony John Mark
Officer
Officer 0
Value: $0
Jun 30, 2025
Buy
Common Stock
J-Other
O'mahony John Mark
Officer
Officer 0
Value: $0
Jun 30, 2025
Buy
Common Stock
J-Other
Lawlor Augustine
Officer
Officer 0
Value: $0
Jun 30, 2025
Buy
Common Stock
J-Other
Baum Jason
Officer
Officer 0
Value: $0
Mar 28, 2025
Buy
Common Stock
M-Exempt
Onsi Douglas E
CEO,cfo,pres.,gc,treas.&sec.
CEO / President 32 500
Value: $10.3K
Mar 28, 2025
Buy
Restricted Stock Units
M-Exempt
Onsi Douglas E
CEO,cfo,pres.,gc,treas.&sec.
CEO / President 32 500
Value: $10.3K
Mar 28, 2025
Buy
Common Stock
M-Exempt
Granfield Christine
Vp, Head Of Reg Affairs/qual
Officer 22 500
Value: $7K
Mar 28, 2025
Sell
Common Stock
F-InKind
Granfield Christine
Vp, Head Of Reg Affairs/qual
Officer 6 604
Value: $2K
Mar 28, 2025
Buy
Restricted Stock Units
M-Exempt
Granfield Christine
Vp, Head Of Reg Affairs/qual
Officer 22 500
Value: $7K
Mar 28, 2025
Buy
Common Stock
M-Exempt
Baum Jason
Chief Scientific Officer
Officer 22 500
Value: $7K
Mar 28, 2025
Sell
Common Stock
F-InKind
Baum Jason
Chief Scientific Officer
Officer 6 604
Value: $2K
Mar 28, 2025
Buy
Restricted Stock Units
M-Exempt
Baum Jason
Chief Scientific Officer
Officer 22 500
Value: $7K
Mar 28, 2025
Buy
Common Stock
M-Exempt
Lawlor Augustine
Chief Operating Officer
C-Suite Officer 22 500
Value: $7K
Mar 28, 2025
Sell
Common Stock
F-InKind
Lawlor Augustine
Chief Operating Officer
C-Suite Officer 7 797
Value: $2K
Mar 28, 2025
Buy
Restricted Stock Units
M-Exempt
Lawlor Augustine
Chief Operating Officer
C-Suite Officer 22 500
Value: $7K
Mar 28, 2025
Buy
Common Stock
M-Exempt
O'mahony John Mark
Chief Manufacturing Officer
Officer 22 500
Value: $7K
Mar 28, 2025
Buy
Restricted Stock Units
M-Exempt
O'mahony John Mark
Chief Manufacturing Officer
Officer 22 500
Value: $7K
Mar 28, 2025
Buy
Common Stock
M-Exempt
Mirabelli Christopher
Chairman Of The Board
CEO / President 22 500
Value: $7K
Mar 28, 2025
Sell
Common Stock
F-InKind
Mirabelli Christopher
Chairman Of The Board
CEO / President 6 672
Value: $2K
Mar 28, 2025
Buy
Restricted Stock Units
M-Exempt
Mirabelli Christopher
Chairman Of The Board
CEO / President 22 500
Value: $7K
Mar 28, 2025
Buy
Common Stock
M-Exempt
Sirard Cynthia
Chief Medical Officer
Officer 22 500
Value: $7K
Mar 28, 2025
Buy
Restricted Stock Units
M-Exempt
Sirard Cynthia
Chief Medical Officer
Officer 22 500
Value: $7K
Mar 28, 2025
Buy
Restricted Stock Units
M-Exempt
Mirabelli Christopher
Chairman Of The Board
CEO / President 22 500
Value: $7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT LEAP THERAPEUTICS INC.
LEAP THERAPEUTICS
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and com...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE